INTRODUCTION
Severe intrauterine bacterial infection (IBI) in the neonates remains a major diagnostic problem because of nonspecific clinical signs and low sensitivity of the routine laboratory tests. Such tests include white blood cell (WBC) count, absolute neutrophil count, immature/total neutrophil (I/T) ratio, and C-reactive protein (CRP) levels which do not establish the diagnosis definitively. In contrast, the ''Gold Standard'', blood cultures are often negative because of low blood volumes drawn and single cultures as well as the prenatal administration of antibiotics. 1 Dealing with preterm neonates, from pregnancies complicated by perinatal infection, is a common clinical practice. The probability of IBI plays an important role in choice of antibiotic and duration of therapy in neonates. 2 Procalcitonin (PCT) is the prohormone of calcitonin. It is a polypeptide with a molecular mass of 12,793 Da. The site of its production, the mechanism of its release and action, and the role it plays in man has still not been well established. PCT is not usually detectable in the serum of healthy adults, but the serum concentration rises markedly during bacterial infection, 3 and therefore it may be a useful tool in the diagnosis of bacterial infections. A rapid increase in the concentration of the serum PCT (2 to 6 hours) occurs in response to the stimulation of endotoxin in healthy volunteers. 4 Further, serum PCT has a long half-life in adults (25 to 30 hours). These characteristics suggest the possible utility of umbilical cord serum PCT concentration as a marker for perinatal bacterial sepsis. 3, 5 Many investigators have described the importance of PCT evaluation in the diagnosis of neonatal infection. [6] [7] [8] [9] [10] [11] [12] [13] [14] However, only a few address the use of PCT concentration in umbilical cord blood for the diagnosis of perinatal sepsis. 6, 9, 13 The objective of this study is to evaluate the usefulness of serum PCT concentration in umbilical cord blood samples in the detection of intrauterine infections in newborns.
MATERIALS AND METHODS
A prospective study was conducted from 2000 to 2001 in the Department of Obstetrics and Perinatology, in the Pomeranian Academy of Medicine, Szczecin, Poland. Serum PCT and CRP levels were evaluated in 187 umbilical cord blood samples.
The patients were assigned to one of five groups as characterized in Table 1 . Group A consisted of umbilical cord blood samples from full-term neonates with appropriate for gestational age (AGA) birth weights, delivered spontaneously by healthy women with no clinical and laboratory evidence of infection and who did not receive antibiotics during pregnancy. In these patients, the postpartum period up to 72 hours was uncomplicated. The B1 group consisted of the umbilical cord blood samples obtained from full-term neonates, without clinical and laboratory evidence of infection, but with maternal and neonatal risk factors such as cesarean section, meconium amniotic fluid, prepartum antibiotic therapy due to existing risk of intrauterine infection, pre-eclampsia, gestational diabetes, Apgar score of r5 at 5 minutes of life, and small for gestational age (SGA). Group C1 included umbilical blood samples of premature newborns meeting the same clinical risk factors as Group B1. In the groups B2 (full-term newborns) and C2 (premature newborns), neonatal infection was diagnosed by the presence of three or more of the following categories of clinical signs: respiratory (apnea, tachypnea, cyanosis or respiratory distress); cardiac (bradycardia or tachycardia); neurologic (hypotonia or seizures); circulation (poor perfusion or hypotension); systemic (irritability, lethargy or poor feeding); or gastrointestinal (hepatosplenomegaly, jaundice or abdominal distension). 15 Chest X-rays and laboratory tests routinely performed in our department such as blood cultures, CRP levels in the umbilical cord and the venous blood, white blood cell (WBC) and thrombocyte count, ratio contributed to the diagnosis of the infection. Cultures of the external auditory duct were obtained immediately after birth.
The study protocol included an evaluation of serum PCT and CRP levels in samples of umbilical cord blood taken simultaneously, and the WBC count in venous blood in the first 24 hours of life.
Umbilical cord blood samples were obtained by umbilical artery puncture directly after the birth of the placenta, and centrifuged within 30 minutes of collection. Serum (40 ml, allowing a double determination) was stored at À701C before analysis. An immunoluminometric assay for the measurement of PCT serum concentration was performed with LUMItest PCT kit (Brahms Diagnostica GmbH, Berlin, Germany) using a luminometer LIA-MAT System 300 (BYK-Sangtec Diagnostica GmbH, Dietzenbach, Germany). The lower detection limit of PCT in this method is 0.08 ng/ml. The PCT values were determined after calibration based on a synthetic PCT of a known value. Assays were performed according to the recommended procedure and completed within 2 hours. 6 The CRP concentration in fresh serum was analyzed routinely by the rate nephelometry method using Olympus AU 560 (bioMérieux Polska, Warsaw, Poland).
A Shapiro-Wilk W-test was used to check distributions of PCT and CRP values and the WBC count. Comparisons between these groups were conducted using the nonparametric Mann-Whitney U-test. The correlation coefficients were calculated according to Spearman's (r S ) correlation test. p-Values<0.05 were considered significant.
A receiver operating characteristic (ROC) curve was constructed to provide a graphical presentation of the results, and to set the cut-off points of PCT and CRP for which the sensitivity and specificity are the highest in the diagnosis of IBI.
RESULTS
In all 187 cases, the PCT concentrations in samples of the umbilical cord blood examined were higher than 0. 5 ng/ml. Concentrations of the serum CRP were <1 mg/l in 136 samples (72.7%). There were no statistical differences in WBC among the five groups examined. In some cases, there were no data for the calculation of the I/T ratio. Figure 1 . Quartile representation of serum PCT concentration (ng/ ml) in umbilical cord blood in the control group A (n ¼ 37); in preterm neonates without intrauterine infection C1 (n ¼ 38) and in infected preterm neonates C2 (n ¼ 24) (p<0.005; C2 vs A and C1). 
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The B2 group included eight blood samples from full-term neonates who had developed an infection in the first few days of life (Table 1) . In all cases, clinical signs and abnormal values in laboratory tests had been present since birth. The PCT serum concentration was not different from the control group, but the umbilical cord CRP concentration was significantly greater than the control group (A). A very strong positive correlation between PCT and CRP was evident.
Group C2 included 24 blood samples of premature neonates with signs and symptoms of IBI. The PCT serum concentration was significantly higher, when compared with the control group (A) and with the premature infants without infection (group C1), respectively, p ¼ 0.002 and 0.003 (Figure 1) . The C2 patients also had a higher CRP concentration when compared with the control group (A). A positive correlation between PCT and CRP was also demonstrable for the C2 group. Table 2 relates the characteristics of the 16 patients with positive surface or body fluid cultures from the 32 diagnosed as having IBI and assigned to either group B2 or C2. In the remaining 16 patients, in spite of clinical and other laboratory signs of infection, repeated surface and body fluid bacterial cultures were negative. Figure 2 shows the sensitivity and specificity of PCT, CRP and WBC in the diagnosis of IBI. The area under the curve (AUC) was 0.75 for PCT, 0.61 for CRP and 0.50 for WBC. The optimum limit of serum PCT concentration to establish the presumptive diagnosis of IBI (cut-off point), obtained by the analysis of the ROC curve, is 1.2 ng/ml. The probability that neonates with PCT serum levels higher than 1.2 ng/ml will develop IBI is 42% (PPV) and with PCT levels lower than 1.2 ng/ml will not develop any IBI is 93% (NPV). The sensitivity and specificity is 69 and 81%, respectively. For CRP, the cut-off point is 2.5 mg/l; the PPV, 19%; NPV, 86%; the sensitivity and specificity is 22 and 97%, respectively. The ROC curve for the WBC count did not differ significantly from the line of nondiscrimination. Table 3 demonstrates the specificity and sensitivity for other values of PCT, CRP and WBC.
DISCUSSION
Serum PCT concentration rises quickly in response to endotoxin (2 to 4 hours), reaches a plateau in 6 hours and decreases gradually to its initial level within 24 hours. 4 Assuming that neonatal kinetics is similar to adults, one can then expect that the concentration of serum PCT in umbilical cord blood would be abnormal in the case of the intrauterine infection. Our results support this assumption, but only for preterm neonates with signs and symptoms of perinatal bacterial infection. In this group, other pathological conditions such as perinatal asphyxia, extreme immaturity, and respiratory distress syndrome could influence the PCT values. 7 Chiesa et al. 6 presented elevated values of the venous blood PCT in different groups of neonates. Higher levels were found in patients with neonatal sepsis. PCT proved to be an effective laboratory marker for diagnosing early-and late-onset infections, and for monitoring the clinical courses of these neonates. 6 In turn, Lapillone et al. 8 found that in cases of severe infection, and in preterm neonates, the serum PCT level was generally higher, but could also be falsely negative. It may be possible, that the production of PCT is low in extremely immature newborns. 8 In our study, the values of PCT in all umbilical cord blood samples were higher than 0.5 ng/ml F beyond the level considered as normal for healthy adults. These results differ from those obtained by Chiesa et al. 6 and Assuma et al., 9 who found the concentration of the serum PCT in the umbilical cord blood samples of healthy neonates, also to be below 0.5 ng/ml. The molecular size of PCT (B13 kDa) does not exclude the possibility of transplacental transport, 10 but precise data in this matter are not available. In turn, the rapid increase in the level of the serum PCT during the first 24 to 36 hours of life observed by many authors, [6] [7] [8] 11 indicates endogenous PCT production by the newborn infant. Many questions concerning the various maternal and perinatal factors that influence the physiological kinetics of PCT during the postnatal period remain unanswered. 9 Pre-and intrapartum administration of antibiotics may affect the umbilical PCT serum levels. Assicot et al. 3 demonstrated a rapid (48 hours) decline in the level of serum PCT after the administration of appropriate antibiotic therapy. As in our study, many neonates demonstrating clinical or laboratory evidence of infection, as well as a positive reaction to antibiotic therapy, had negative blood cultures. 1, 6, 12 Our results show that PCT levels in umbilical cord blood samples appear to be more sensitive than CRP in the diagnosis of IBI, a conclusion consistent with the studies of Janota et al. 13 This may be because of the slower rate of rise of CRP when stimulated by perinatal infection. Thus, CRP may be better for the diagnosis of late, in comparison with early neonatal infection 14, 17 when the decision to administer postnatal antibiotics must be made before the CRP rise.
More studies are necessary to establish the reliability of using the level of serum PCT levels in the diagnosis of IBI.
CONCLUSIONS
Serum PCT concentration in umbilical cord blood samples from preterm infants with IBI is significantly higher than those in fullterm neonates without IBI as well as in preterm newborns without IBI.
The optimal cut-off point in determining concentrations of serum PCT in umbilical cord blood is 1.2 ng/ml, for which maximum sensitivity and specificity is needed to establish the diagnosis of IBI. PCT may become a useful laboratory marker for diagnosing neonatal infection.
